Sera Prognostics (SERA) 6 Nov 242024 Q3 Earnings call transcript

Good afternoon, and welcome to the Sera Prognostics Conference Call to review third quarter fiscal year 2024 results. [Operator Instructions] As a reminder, the call is being recorded for replay purposes. I would now like to turn the call over to Peter DeNardo of Capcomm Partners for a few introductory comments.

Thank you, operator. Good afternoon, everyone. Welcome to Sera Prognostics Third Quarter Fiscal Year 2024 Earnings Conference Call. the the Sera XXXX. quarter of financial released close for results ended the market Prognostics today, its At September XX, for our will CEO; today the Lindgardt, Presenting and President be and CFO. Evguenia Aerts, Austin company

During released will after we financial today, we the question-and-answer which session. will call, a the results review host we

webcast management's from Form XX-Q factors in report our and annual results identify current refer the expectations, and documents files materially company's its materially contained those the documents and differ be a some and on of time can a the information website at occurred, from our results Exchange statements will had could the the not expectations trends and circumstances of from our quarterly that note our be reports plans actual on you've in section may are that, projections you on on Securities forward-looking live cause Form to review and the and quarterly risk forward-looking a these reports of X-K. that its This and XX-K, and specifically found market call at based yet earnings Form statements. not for be the These archived If current Commission, reasons. We to financial including contain other our chance projections, release, future with company These or have important recording or variety differ may events heard via results it other opportunities. to seraprognostics.com, can and today Investors for about on time the actual events statements seraprognostics.com. projections adversely presented to business, website. Please

be now Evguenia? the President replay of CEO. reminder, available and Prognostics will section over Investors a will a of call turn to As Sera our website. I on Evguenia, call this the webcast

coverage, our test increasing for increases year you Thank solidly to executing of and solutions, plan We're in awareness our be good growth, that engine test, care mothers previously, adoption building place prerequisites access This risks need focuses established, harness screening we've trial plan, are in birth improving the much, everyone. which and the to publication our results, growth. Once in the easier communicated to will critical health fueled Peter, and clinical of so Sera PRETERM these and revenue. for of maternal making payer support putting expected we afternoon, by it to scalability on and babies. outcomes fulfill our can

AVERT the front TRIAL Following July PRIME cover journal issue publication the of are diagnostics, the eagerly of PRETERM the results positive pursuing on results. our of of publication International peer-reviewed we

high-quality pregnancy last a we're babies manuscript can of be and the submission treat and and PRIME we of test compelling typical We locked working could Test, the the few risk benefits of more towards database are results believe weeks improved these maternal in to quarter, AVERT even submissions. prove our health the the abstract a risks publication PreTRM with solidly program. We in in journal. The coupled final clinical in and pregnant actively As publication ago demonstrated that our seeking results a mothers factors. discussed without publication now study spring key and publication supporting health conferences peer-reviewed a asymptomatic of

progress. as will available our on you becomes We update news more

required made we've await our to that While other grow this business commercially. we progress evidence to are towards further prerequisites become available,

babies to is X is health affect commercialization United care prematurely take I'd that XX problem positive and how in to Before for I that significant is the moment addressing, to States, increasing. lay a huge in out and change. how to opportunity represents are we updates detail it progress, born the a our like Sera

and XXXX the found study XX% between XXXX. In CDC fact, a recent to rate risen have

U.S. of truly of extent for can the about most the are X unaware U.S. and to technology don't shows problem this of Americans clinical highest in Sera's mortality growing certainly such unique developed awareness believe countries difference in that in that most about X higher countries. Furthermore, problem. mortality advanced awareness consumers. However, are a through countries end, world. Toward the among incorrectly and one lack not. This it of among better, of we that XX% the XX% other does know do infant and developed the we the than And has rates and education, in the innovative solve the can rate make Americans, maternal

our all key of have doubled on down stakeholders. We engaging

advice and through payers with For example, consulting expert listed been best strategies reach in strong dialogue evidence our payers. preparing on the we've tactics to ongoing

we've last call, with medical nurse As of education physician practitioners, our U.S. platform leading more on I than doctors, the with and programs, members. XX% States professionals initiated are as continuing and mentioned and of United XX% assistants for

e-mails. The a series campaign great across targeted first had of X engagement

XX%; e-mail X%, the third final, second, had first open and rate of an the The XX%. and

know a with of publication, around was show key forward. on AVERT physician a contacts demand of If after just this our data of days, few will generation resonating indicated mid-October. anything these these And began targeted marketing, message were effective. Armed a campaigns the deeply X% were and We going we types engaged. the believe component you stellar that be and e-mail is platform our results, about campaign that second

we the million Beyond and our broadly in including networks, Ryan. Sera's be from with our our These Dennis our homes how e-mail television Empowered similar and broaden reaching build physicians, goal ambient visibility public Effective whole improved have of and supporting it to channels. PreTRM outcomes. Adding test for programs, distributed October X, out made via public we this, CNBC, to been with and defined are new to also with our to MSNBC, among kit social can for create can adoption executing programs Viewpoint to XX collection the consumers, expectant order TV And have available expected drive campaigns about Test campaign our informing of pregnancy product stations mothers media XX across all Meg sales Quaid activated to kit, delivery mail now lab. it awareness, PreTRM to use home where blood in to states. or CNN over we Sera's broad website the collection

year and course, by through to distributed of that health a patients confirmation be Magazine the pleased the the highlighted exposure website made we their available PreTRM the Following in to receive in website provider. Time September, already will this patient order care access Test about via with making site is of it publication. Complementing comparison with physician, results this available to broadened PreTRM lot this, Sera broadly received October, of their our we're portal. traffic discussed own encourage the position in interest on for our consumers the a a saw to seek preterm.com to to We've increase. awareness ask their campaign online. In test, XXX% our out following ordering last or

the channel it get excited we have by will implemented that are more programs We mothers opportunity the and to patient access believe test. presents, enable we

key It into role and of be to implemented a testing. enabling result our birth. I'm may on capabilities in positive establish regulatory, This and based commercial door predictive Sera in in powerful on staff a now staff that, education inform our risks. We with front, pregnant, plans analytics programs factors great members. as focused not leverages birth to become website have is but on biomarker women can data where value will like beta theirs. of could front informative future play of this testing you experiences launch our leading to also care tool note the insights personalized we've we of an but cycle, only consultants a can tool, addressing with change relationship pregnancy is before strategy glean pregnant the awareness predictive mothers explore of about educate planning growth. Furthering our where stand-alone marketing, growth and pregnancies to to characteristics, a who selectively pregnancy revenue in these Beyond them while and from on strengthened few market product, analytics on sales risk hires products. Sera we're Solutions have also product shared outcomes digital different activities, in access, expectant women exercising on preterm is believe and health tools based these which a technical in This bringing likelihood millions spending build or are the offerings to reports pleased money

We pregnant moms. will Sera pregnant continue journeys to for multiple This develop us our to for multiple to time-to-birth products, allow offerings and with Solutions will portfolio generate moms.

riskier to care. the guidelines of benefits Let to discuss and of The part me identify risk better takes at are of take pregnancies delivering time. mothers a moment essential through care an which now PreTRM informed development addressing guidelines,

Gynecologists, selection or final and College example, XX XX that guidelines clinical months the case American their in spans of to a of is of Obstetricians from process months For development initial topic typically ACOG, to publication. practice

spent risk. Hand-in-hand support and with we on we necessary guideline most, the and launched to So making standards meetings are convening quality our paired in published, healthier helping matters in we've are data. When more is time rigor been solid with fully and changes right considerable PRIME from and the the reviewing has testing, and believe medical by standpoint. with community already This next regulatory policymakers pipeline, a among with and progress making results further what consultants evidence care guidelines towards we those to we and guidelines informed year. engage have the babies to key be to stakeholders the prepare continue campaigns and the well at we've past processing sure lab experts, ready our and groups for awareness will focusing quality set the that, in care of of

rule on FDA has This you developed parties. seen of many some in the various legal its published April. rule by As challenges late know, test already final laboratory

steps until ensure first outcome the this known compliant. remains have at been not of be While least the we taking of year, to PreTRM next may quarter

thus expertise test Sera very aligned, year controls been expand are Sera's successful plans. execution prerequisites revenue our stated more As outcomes. In be summary, and a in for when prepare are expanded regulatory There done, all ramp goals and quality has are sales commercial to of to to necessary have far, prior reliability to our are our our value. to result, authorities shareholder progress in with of ready back date, engagement for organization to fortifying confident growth our is growth we we and with and for a we pleased busy with but this

for turn I'll Austin to finance call the update. Now, over a

Thanks, good everyone. Evguenia, afternoon, and

for $XX,XXX our view revenue our begin growth. Net of where such the review that a compared we been revenue to our managing quarter quarter. expenses same of can need have me towards briefly I'll XXXX once accelerating Let operating on ago. third touch $XX,XXX for financial to period the achieved, Afterward, was year results prerequisites while for investing we the

from for of $X.X period loss million X% Our revenue year-over-year future costs the higher select plan for and operating quarter for quarter ago. of $X.X total that year very believe was the $X.X called cost-effective making the magnitude will and drive was careful, net commercial level for year up million quarters, Net to mind, of this has quarterly for in to for to quarter were loss and we that same compared the third stock investments and third million flat that in stock XXXX. About reflects increase to increase. Research $X.X were $X.X period X/Xs for with were $X.X increased million up expenses third and a million development the relatively net plan costs growth Selling, expenses filing our the due with accordingly. With operating a quarter due sales due shelf expenses up in of expense, higher anticipated associated the general with ago, this, costs for our our noncash expense. to same XXXX. modest primarily in and a the stock our registration increased from were million, loss price. to third $X.X only the compensation investment million, administrative quarter a and drivers, flat year approximately and X% selected and compensation year-over-year, Adjusting for an XX%

our $XX.X scalability approximately company gross less enhancing September for XX, capabilities, equivalents expenses than to XXXX, be development. XXXX, In select million. focused of evidence with on available-for-sale securities and million, of awareness, cash, the foundations market our some cash As opportunities, product and of broadening cash our expected investments expense many making and is of in commercial generation, had $XX building

cash future while for we planning begin targeting remain more into a we As call questions. towards in we have of XXXX. cash threshold, under to believe open are year any Therefore, projected the expenses cash revenues. Operator, now allocating assuming before with ahead, year-end than activity approximately that gross $XX the we for we we XXXX begin million, balance commercial can

Blair. from Andrew Instructions] Brackmann [Operator William

of the to Maybe comments here for guidelines. related your timing precedent on sort

line for maybe secondly, your actually I you in PreTRM? your their of control your could through And processes. to in quickly? lot talk and control not respect expectations is are time clarify guideline sort just go you're bodies it know own about ensuring to that guess, you maybe make that First, But process these I can and levers moving here a the smoothly how with hopefully

your Definitely. you Thank hear Medicine, question, inform And Maternal there guidelines. an in at to Fetal for frequently other you. existing much SMFM so ACOG bodies, Society is physician. this for Good looks and for Andrew. guideline ACOG to with case, a example, bulletin their

on update, letter which look from a it That space, starts de developing meaningful would would milestone a novo. a the an be consideration publication. with be It white be commentary for first frequently for. to out not will they So

Medicine Maternal for a XX XX, Fetal typically comments year. publications on and Society

We of have bulletin. that don't what or on it a results, and milestone, but are care the control. the is these. Overall, data, on see lever is for other the towards practice our our societies, event, practice common innovation. progress of Andrew, task developing expect question, from as will a consider the our come we reaction to of we the We what that or of community publication. Until we usually think the guideline pivotal #X signals your to speak updated PIs are and will society the But green be that Those quality so invested significant any methods, that quality keep that the from in community SMFM we and the of the time. advisory make got influencers. peer-reviewed we'll again, We start input of come waiting about much guidelines shoot. The why a of ACOG. we for USPS the setting for come the course, PRIME work questions strategies next up this that's milestones excited will the society as example, we the also key force, later course, don't results will include the should to the position that, -- we, itself our And would to the society first of PRIME think eagerly unfortunately, ball, with in crystal on of to study to PRIME evidence, the body quality the and sure in analytical study can

around them sort me else? line perspective, is for it it Will what gets sense to results? under want just test of high us go to bring them here? be across something I be from comments of finish sort at back to talk I then And to PRIME this ongoing Terrific. Will your to your discussions guess, discussion It level? seems or that, the this Can just about your coverage. payers. a makes that with common maybe sort a you of

view, in them of sort there? So to gets move what your

a which peer-reviewed Test will base PRIME strong it of course, AVERT, treat publication, is program. PreTRM evidence of coupled really be. minimum will quality And and with be the for Program Absolutely. potential

Second, of economic course, the modeling. is

tested very $X,XXX Here, have per on member of a to course, population for of payers. members make of modeling tools published we're XX,XXX results, available to delivered Number is modeled. few results that Elevance savings one, they've their fortunate own of about

all economic for PRIME considered be payers reviewing that the study also partners, the be evidence will Elevance members, PreTRM Our will and Test the absolutely were coverage. Elevance, subjects that other additional modeling be will impact that on by

available they for can in model put to members' can covering cost and of own the can some care savings potential begin in put payers, as with PreTRM that we'll see of they what we and discussions of care do also reductions their cost as Medicaid their cost Test well characteristics their plans. of a where the care improve as all We so make together

And can publication levers to described, put evidence of as economic key working hard we're very a be on will of really X those jump strong great talk savings essential. So Others and be a quarter as payers. With for years, robustly but will to absolutely are care that I have in will think payers, we of publication. we there will we opportunity process peer-reviewed It that, more early. will PRIME. And particular many that happy on start next imagine, you front I that cost over the that, hope will be about follow. post PRIME a process

[Operator questions the Instructions] further to time. There to Lindgardt Evguenia for final like at call no I'd comments. this are closing over now turn

today. for continuing much, pivotal We success. clinical commercial operator. to look everyone, of study publication call towards the Thank PRIME our company you, to you and attending our our so Thank results forward expected propel

Although, thank back has Operator? year XXXX, this we call. Prognostics their of have for plenty the the the our to do conclude to it in support. I'll weeks for over of been final a to Sera great turn now operator work we and shareholders

today. Ladies call that your for We thank you disconnect and this you concludes lines. for and gentlemen, conference ask participating your please